TCL Archive ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs. March 7, 2008
TCL Archive Rauscher May Set Up New Office To Monitor, Coordinate RFPs And Grants, Stop Duplication May 2, 1975
TCL Archive The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data September 25, 1998
